Cargando…
Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder
Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects w...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895691/ https://www.ncbi.nlm.nih.gov/pubmed/20351719 http://dx.doi.org/10.1038/mp.2010.24 |
_version_ | 1782183282020974592 |
---|---|
author | Cannon, DM Klaver, JK Gandhi, SK Solorio, G Peck, SA Erickson, K Savitz, J Akula, N Eckelman, WC Furey, ML Sahakian, BJ McMahon, FJ Drevets, WC |
author_facet | Cannon, DM Klaver, JK Gandhi, SK Solorio, G Peck, SA Erickson, K Savitz, J Akula, N Eckelman, WC Furey, ML Sahakian, BJ McMahon, FJ Drevets, WC |
author_sort | Cannon, DM |
collection | PubMed |
description | Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects with major depressive disorder (MDD) and healthy controls (1). In the current study we investigated the effects of six single nucleotide polymorphisms (SNP) for CHRM2 on M(2)-receptor binding to test the hypotheses that genetic variation in CHRM2 influences M(2)-receptor binding and that a CHRM2 polymorphism underlies the deficits in M(2)-receptor V(T) observed in BD. The M(2)-receptor V(T) was measured using PET and [(18)F]FP-TZTP in unmedicated, depressed subjects with BD (n=16) or MDD (n=24) and healthy controls (n=25), and the effect of genotype on V(T) was assessed. In the controls one SNP (with identifier rs324650, in which the ancestral allele adenine (A) is replaced with one or two copies of thymine (T), showed a significant allelic effect on V(T) in the pregenual and subgenual anterior cingulate cortices in the direction AA<AT<TT. In contrast, in BD subjects with the TT-genotype V(T) was significantly lower than in BD subjects with the AT-genotype in these regions. The BD subjects homozygous for the T-allele also showed markedly lower V(T) (by 27 to 37% across regions) than healthy controls of the same genotype. Post hoc analyses suggested that T homozygosity was associated with a more severe illness course, as manifested by lower socioeconomic function, poorer spatial recognition memory and a greater likelihood of having attempted suicide. These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2. The differential impact of the M(2)-receptor polymorphism at rs324650 in the BD and HC samples suggests interactive effects with an unidentified vulnerability-factor for BD. |
format | Text |
id | pubmed-2895691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
record_format | MEDLINE/PubMed |
spelling | pubmed-28956912011-10-01 Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder Cannon, DM Klaver, JK Gandhi, SK Solorio, G Peck, SA Erickson, K Savitz, J Akula, N Eckelman, WC Furey, ML Sahakian, BJ McMahon, FJ Drevets, WC Mol Psychiatry Article Genetic variation in the cholinergic-muscarinic2 (M(2))receptor gene (CHRM2) has been associated with the risk for developing depression. We previously reported that M(2)-receptor distribution volume (V(T)) was reduced in depressed subjects with bipolar disorder (BD) relative to depressed subjects with major depressive disorder (MDD) and healthy controls (1). In the current study we investigated the effects of six single nucleotide polymorphisms (SNP) for CHRM2 on M(2)-receptor binding to test the hypotheses that genetic variation in CHRM2 influences M(2)-receptor binding and that a CHRM2 polymorphism underlies the deficits in M(2)-receptor V(T) observed in BD. The M(2)-receptor V(T) was measured using PET and [(18)F]FP-TZTP in unmedicated, depressed subjects with BD (n=16) or MDD (n=24) and healthy controls (n=25), and the effect of genotype on V(T) was assessed. In the controls one SNP (with identifier rs324650, in which the ancestral allele adenine (A) is replaced with one or two copies of thymine (T), showed a significant allelic effect on V(T) in the pregenual and subgenual anterior cingulate cortices in the direction AA<AT<TT. In contrast, in BD subjects with the TT-genotype V(T) was significantly lower than in BD subjects with the AT-genotype in these regions. The BD subjects homozygous for the T-allele also showed markedly lower V(T) (by 27 to 37% across regions) than healthy controls of the same genotype. Post hoc analyses suggested that T homozygosity was associated with a more severe illness course, as manifested by lower socioeconomic function, poorer spatial recognition memory and a greater likelihood of having attempted suicide. These data represent novel preliminary evidence that reduced M(2)-receptor V(T) in BD is associated with genetic variation within CHRM2. The differential impact of the M(2)-receptor polymorphism at rs324650 in the BD and HC samples suggests interactive effects with an unidentified vulnerability-factor for BD. 2010-03-30 2011-04 /pmc/articles/PMC2895691/ /pubmed/20351719 http://dx.doi.org/10.1038/mp.2010.24 Text en Users may view, print, copy, download and text and data- mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms |
spellingShingle | Article Cannon, DM Klaver, JK Gandhi, SK Solorio, G Peck, SA Erickson, K Savitz, J Akula, N Eckelman, WC Furey, ML Sahakian, BJ McMahon, FJ Drevets, WC Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title | Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title_full | Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title_fullStr | Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title_full_unstemmed | Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title_short | Genetic Variation in Cholinergic-Muscarinic-2 Receptor Gene Modulates Muscarinic(2)-Receptor Binding In Vivo and Accounts for Reduced Binding in Bipolar Disorder |
title_sort | genetic variation in cholinergic-muscarinic-2 receptor gene modulates muscarinic(2)-receptor binding in vivo and accounts for reduced binding in bipolar disorder |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895691/ https://www.ncbi.nlm.nih.gov/pubmed/20351719 http://dx.doi.org/10.1038/mp.2010.24 |
work_keys_str_mv | AT cannondm geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT klaverjk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT gandhisk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT soloriog geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT pecksa geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT ericksonk geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT savitzj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT akulan geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT eckelmanwc geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT fureyml geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT sahakianbj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT mcmahonfj geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder AT drevetswc geneticvariationincholinergicmuscarinic2receptorgenemodulatesmuscarinic2receptorbindinginvivoandaccountsforreducedbindinginbipolardisorder |